Company / Capital Expenditures
LivaNova Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$81.0M
FY2025
5-year range
$24.7M / $81.0M
FY2021-FY2025
Trend
+72.1%
vs FY2024
Sector context
#70 of 151
Health Care
What the data says
At $81M, LivaNova's capital expenditures ranks #70 of 151 in the Health Care sector. Capital Expenditures has fluctuated over the past 10 years, ranging from $25M in FY2021 to $81M in FY2025.
Based on SEC 10-K filings.
$81M in FY2025 with a 5-year CAGR of +18.3%.
Improved from $35M to $81M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +32.3%
- 5-Year CAGR
- +18.3%
- 10-Year CAGR
- -
Sector benchmark
#70 of 151 in Health CareTop 46% of 151This company $81.0M Sector average $271.7M
▼
-70.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +18.3%, indicating consistent growth.
- In FY2025, capital expenditures increased 72.1% year-over-year.
- Ranks #70 out of 151 companies in the Health Care sector.
- Lowest capital expenditures in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.84 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $81.0M | +72.1% |
| FY2024 | $47.1M | +34.7% |
| FY2023 | $35.0M | -0.1% |
| FY2022 | $35.0M | +41.8% |
| FY2021 | $24.7M | -29.5% |
| FY2020 | $35.0M | +41.8% |
| FY2019 | $24.7M | -33.6% |
| FY2018 | $37.2M | +12.9% |
| FY2017 | $32.9M | -14.2% |
| FY2016 | $38.4M | +121.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026